Clinical Report: Reimbursement and Coding for OCT Angiography in 2025
Overview
The 2025 CPT Handbook introduces a new procedure code 92137 for OCT angiography (OCTA), enabling standardized reporting and reimbursement. OCTA offers a non-invasive, dye-free imaging technique for retinal and optic nerve vascular assessment, with a Medicare allowable fee of $57 for bilateral testing.
Background
Optical coherence tomography angiography (OCTA) is an advanced imaging modality that provides high-resolution, non-invasive visualization of retinal and choroidal vasculature without the need for dye injection. It improves upon traditional OCT by offering en face transversal imaging, aiding diagnosis and monitoring of various retinal, optic nerve, uveitis, and neurological conditions. The new CPT code 92137 facilitates billing for OCTA, but payor coverage and documentation requirements remain evolving. Clinicians must understand coding nuances and patient financial responsibilities due to limited payer policies.
Data Highlights
| Parameter | Value |
|---|---|
| CPT Code | 92137 |
| Procedure Description | Computerized ophthalmic diagnostic imaging, retina including OCT angiography |
| Medicare National Allowable Fee (2025) | $57 (unadjusted) |
| Technical Component | $23 |
| Professional Component | $34 |
| Payment Basis | Bilateral (one or both eyes) |
| Medicare MPPR | Applies to technical component when multiple tests performed same day |
Key Findings
- CPT code 92137 is newly introduced for OCT angiography, covering unilateral or bilateral retinal imaging with interpretation and report.
- OCTA provides non-invasive, dye-free imaging of retinal and choroidal vessels using motion contrast from red blood cells, reducing risk and procedure time.
- Clinical indications include diabetic retinopathy, AMD, vascular occlusions, glaucoma-related optic nerve changes, uveitis, and neurological diseases such as Alzheimer’s.
- Medicare’s 2025 allowable fee is $57 total, split between technical ($23) and professional ($34) components, with payment considered bilateral.
- Documentation must be thorough, detailing findings and image storage location; vague notes like “abnormal” are insufficient.
- Payor coverage is currently limited and variable; patient financial responsibility may be necessary with appropriate notices such as ABN or NEHB.
Clinical Implications
Clinicians should familiarize themselves with CPT 92137 coding guidelines and ensure comprehensive documentation to support claims. Due to limited payer policies, it is essential to inform patients about potential out-of-pocket costs and obtain necessary advance beneficiary notices. Monitoring claim processing and reimbursement patterns will help optimize practice workflows and financial planning.
Conclusion
The introduction of CPT code 92137 for OCT angiography marks an important step in standardizing reimbursement for this advanced imaging modality. Careful attention to coding, documentation, and patient communication will facilitate appropriate utilization and coverage.
References
- Koustenis et al. 2017 -- Optical coherence tomography angiography: an overview of the technology and an assessment of applications for clinical research
- Leitgeb 2019 -- En face optical coherence tomography: a technology review
- Le PH et al. 2024 -- Optical Coherence Tomography Angiography, StatPearls
- AAO EyeWiki -- Optical coherence tomography angiography
- Rifai et al. 2021 -- The application of optical coherence tomography angiography in Alzheimer’s disease: A systematic review
- First Coast Solutions Medicare Administrative Contractor
- Novitas Solutions Medicare Administrative Contractor
- 2025 CPT Professional Edition
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







